-+ 0.00%
-+ 0.00%
-+ 0.00%

KAIROS PHARMA: TO EVALUATE CO'S LEAD ANTIBODY ENV-105 WITH BAYER'S XOFIGO IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Reuters·07/22/2026 12:35:02

Please log in to view news